We have been involved in diabetes and product research since 2002. The Company was established in 2003, with focus on addressing consumers’ healthcare concerns through nutraceutical dietary supplements formulated from whole grain derivatives. Nutraceuticals are nutrient dense functional foods, ‘medical foods’ by definition, that have been tested and performance proven to help mitigate certain health risks.

The Company’s research and product development initiatives focus on bringing clinically tested nutraceutical formulations to consumers who are seeking performance proven nutritional supplements to meet their daily healthcare concerns. The Company’s initial product introduction is Diabatrol™, a nutraceutical dietary supplement specifically formulated for helping lower blood glucose levels and reducing insulin resistance in
Type II diabetics, pre-diabetics and individuals seeking to reduce the potential health risks associated with diabetes.

In order to assure consumers the highest product integrity, the Company policy requires that all its products meet the regulatory requirements of the U. S. Dietary Supplements, Health and Education Act overseen by the Food and Drug Administration, and enforced by the Federal Trade Commission.